Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy

Loading...
Thumbnail Image

Embargo End Date

Authors

Bergh, J
Swain, SM
Cameron, D
Albain, K
Anderson, S
Arriagada, R
Ballman, K
Bartlett, J
Bergsten-Nordstrom, E
Bliss, J
Bradley, R
Brain, E
Braybrooke, J
Carey, L
Choudhury, A
Clarke, M
Coleman, R
Cuzick, J
Davidson, N
Del Mastro, L
Dignam, J
Dodwell, D
Dowsett, M
Duane, F
Ejlertsen, B
Foukakis, T
Francis, PA
Garcia-Saenz, JA
Gelber, R
Gnant, M
Goetz, MP
Goodwin, P
Gray, R
Hayes, D
Hill, C
Hills, RK
Jagsi, R
Janni, W
Loibl, S
MacKinnon, E
Mamounas, E
Mannu, G
McGale, P
McIntosh, SA
Meisner, A
Mukai, H
Nekljudova, V
Norton, L
Pan, H
Peto, R
Piccart, M
Poortmans, P
Pritchard, KI
Raina, V
Rea, D
Regan, MM
Robertson, J
Saji, S
Salgado, R
Sharma, P
Slamon, D
Spanic, T
Sparano, J
Spears, P
Steger, G
Tang, G
Taylor, C
Toi, M
Tutt, A
van Duijnhoven, F
Viale, G
Wang, X
Whelan, T
Wilcken, N
Wolff, A
Wolmark, N
Yu, K-D

Document Type

Journal Article

Date

2025-08-09

Date Accepted

2025-08-09

Abstract

Citation

The Lancet, 2025, 406 (10503), pp. 603 - 614

DOI

Source Title

The Lancet

Publisher

ELSEVIER SCIENCE INC

ISSN

0140-6736

eISSN

1474-547X

Collections

Research Team

Clin Trials & Stats Unit

Notes